KARADA内科クリニック
JUST IN CASE is a Japan-wide online telemedicine clinic operated by KARADA内科クリニック that prescribes and delivers HIV PrEP, HIV PEP, DOXY PEP, and at-home STI tests via LINE-based consultations and Yamato shipping for individual Japanese consumers.
- Company typePrivate
- Founded-
- HeadquartersTokyo, Japan
- Headcount—
- GTM typeB2C
- OfferingServices
What KARADA内科クリニック does
KARADA内科クリニック (KARADA Internal Medicine Clinic) is a private medical corporation (医療法人社団OURS) headquartered in Gotanda, Tokyo, that operates a nationwide Japanese online telemedicine service branded JUST IN CASE. Its core function is the prescription and direct-to-consumer delivery of medications for sexually transmitted infection (STI) prevention: HIV PrEP (Tafero EM, daily or on-demand), HIV PEP (Taffic, a 30-day post-exposure course), and DOXY PEP (doxycycline, for syphilis, gonorrhea, and chlamydia post-exposure prophylaxis), supported by optional at-home STI test kits. Consultations are conducted entirely through LINE (no dedicated app required) with physicians credentialed in infectious disease, and medications are shipped discreetly via Yamato Transport with home delivery or locker pickup.
The underlying technology is a web + LINE-based synchronous telemedicine workflow integrated with mail-order pharmacy fulfillment and shipping logistics. Pricing is unit-based for single courses and subscription-based for ongoing PrEP (28–80 day cycles) and DOXY-PEP (28-day regular delivery). Patients also pay separately for optional postal STI tests. The only disclosed integration is the LINE Official Account used as the primary booking and consultation surface.
The business model is a direct-to-consumer specialist clinic monetizing prescription consultations and medication fulfillment, with subscriptions on PrEP and DOXY-PEP providing recurring revenue and PEP functioning as a high-ticket one-off. The customer base is horizontal: individual Japanese adults with elevated HIV/STI risk who are seeking discreet, rapid access to prevention medications and testing. The affiliated physical KARADA内科クリニック 五反田 clinic serves as a referral point for in-person consultations. Since launch, JUST IN CASE has expanded its scope to include additional "delicate" categories such as 肥満症 (obesity), ED, and AGA.
KARADA内科クリニック firmographics
Firmographics- Name
- KARADA内科クリニック
- Legal name
- 、医療法人社団OURS
- Website
- https://just-in-case.jp
- Company type
- Private
- Operating status
- Operating
- Short description
- JUST IN CASE is a Japan-wide online telemedicine clinic operated by KARADA内科クリニック that prescribes and delivers HIV PrEP, HIV PEP, DOXY PEP, and at-home STI tests via LINE-based consultations and Yamato shipping for individual Japanese consumers.
- Ownership category
- akta.pro rank
KARADA内科クリニック industry classification
Industry- Product category
- Online Telemedicine Healthcare Services
- NAICS
- Offices of Physicians (except Mental Health Specialists) (621111), Other Ambulatory Health Care Services (6219)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment (HLALAIAL)
- akta.pro secondary industries
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA), Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)
Keywords
Where KARADA内科クリニック is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
KARADA内科クリニック business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- HIV PEP prescription and medication sales: One-time prescription sale of HIV post-exposure prophylaxis (PEP) medication (Taffic), including 30-day supply of antiretrovirals, physician consultation, and an at-home HIV/hepatitis B test kit. Additional optional follow-up consultation available.
- HIV PrEP prescription and medication sales: Prescription and sale of HIV pre-exposure prophylaxis (PrEP) medication (Tafero EM / generic), available as daily or on-demand dosing. Sold as one-time purchase, or via subscription with scheduled refills (28–80 day cycles). Includes at-home test kit sets (start, minimum, standard) for HIV/hepatitis B/syphilis screening. 6-month prescriptions require prior Tafero EM use history.
- DOXY PEP prescription and medication sales: Prescription and sale of doxycycline post-exposure prophylaxis (DOXY PEP) — an antibiotic regimen for prevention of syphilis, gonorrhea, and chlamydia after sexual contact. Sold in packs of 1, 5, 10, 20, or 30 doses, with optional subscription (regular delivery every 28 days) and optional add-ons (probiotics, anti-nausea medication). Regular at-home testing strongly recommended and required for continued purchase.
- Optional postal STI testing: Mailed self-collection STI test kits sold as add-ons to prescription services: HIV/hepatitis B (home test, immediate results), syphilis, gonorrhea/chlamydia (mailed to clinic, results in 3–4 days after receipt).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | HIV PEP — single 30-day course (Taffic) |
| Unit Pricing | Pay-as-you-go | DOXY PEP — single-dose packs |
| Subscription | Monthly | DOXY PEP — subscription (regular delivery) |
| Unit Pricing | Pay-as-you-go | HIV PrEP daily — one-time purchase (no test kit) |
| Unit Pricing | Pay-as-you-go | HIV PrEP daily — one-time purchase (with test kit set) |
| Unit Pricing | Pay-as-you-go | HIV PrEP on-demand — single bottle (30 tablets) |
| Unit Pricing | Pay-as-you-go | Optional postal STI tests |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
KARADA内科クリニック product offering
Product offeringCore offering
KARADA内科クリニック runs the JUST IN CASE online telemedicine service that provides remote physician consultations and prescriptions for STI prevention medications, including HIV PrEP (Tafero EM), HIV PEP (Taffic), and DOXY PEP (Doxycycline). Consultations are conducted entirely via LINE without requiring app installation, and prescribed medications are shipped nationwide via Yamato Transport with next-day delivery, discreet plain packaging, and optional locker pickup. The service also sells optional at-home STI test kits for HIV, hepatitis B, syphilis, gonorrhea, and chlamydia.
Product overview
JUST IN CASE is an online telemedicine service operated by KARADA内科クリニック (KARADA Internal Medicine Clinic), offering prescription medications for sexually transmitted infection (STI) prevention. The core product portfolio consists of three main offerings: HIV PrEP (プレップ) with TAFFERO EM for pre-exposure prevention, HIV PEP (ペップ) with Taffic for post-exposure emergency prevention, and DOXY PEP (ドキシペップ) using Doxycycline for prevention of syphilis, gonorrhea, and chlamydia. All services are delivered through online medical consultations with certified infectious disease specialists, with medications shipped discreetly via Yamato Transport. Optional mail-in test kits complement these offerings for pre-treatment screening and post-treatment verification. The service operates as a direct-to-consumer online clinic, distinct from the affiliated physical KARADA内科 clinics.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- HIV prevention effectiveness of 99%+ with consistent daily PrEP use
- +2 more outcomes
Companies that use KARADA内科クリニック
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
KARADA内科クリニック technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature2 records
KARADA内科クリニック partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, flagship and minor.
- Hetero Drugs (ヘテロー Drugs / Hetero社)coreHetero Drugs is an Indian multinational pharmaceutical company that manufactures Tafero EM (タフェロEM) as a generic antiretroviral. JUST IN CASE imports the generic version (Tafero EM / Instgra) through licensed pharmaceutical importer つばめLabo for use in its PrEP program. Hetero's generic is described as having no significant safety difference from originator drugs and being widely used internationally.
- KARADA内科クリニック (physical clinic)coreKARADA内科クリニ is the affiliated physical clinic operated by Medical Corporation OURS. It serves as the physical referral destination for patients using the JUST IN CASE online service who prefer or require in-person consultations, as well as the physical location where the online service's medical director and staff are based.
- 大阪大学 忽那教授 (Professor Kutsuna, Osaka University)flagshipProfessor Kutsuna of Osaka University, a leading infectious disease researcher, collaborated with Dr. Sato on an in-depth YouTube discussion about DOXY-PEP. This collaboration serves as a key educational and credibility partnership, lending academic authority to JUST IN CASE's DOXY-PEP offering.
- AbemaTV (アベプラ)minorThe JUST IN CASE DOXY-PEP service was featured on AbemaTV (Abema News), providing earned media coverage that drives awareness and customer acquisition.
- つばめLabo (Tsubame Labo)coreLicensed pharmaceutical importer that sources and imports generic antiretrovirals (Tafero EM and Instgra) from Hetero Drugs and other overseas manufacturers for use in the JUST IN CASE PrEP program. Acts as the import compliance and supply chain partner for overseas generic medications.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
KARADA内科クリニック competitors and assessment
Company assessmentDirect peers
- Nurx: US DTC telehealth platform (now part of Thirty Madison) historically offering PrEP, STI testing, contraception, and home delivery prescriptions. Closely comparable model on PrEP/STI prevention telemedicine with at-home testing integration.
- あおぞらクリニック (Aozora Clinic): Japanese clinic network with multiple locations explicitly marketing HIV PrEP services online. Closest direct domestic peer — competes for the same PrEP/PEP patient persona in Japan with overlapping telemedicine and consultation offerings.
- MISTR: US-based, PrEP-focused telehealth platform providing online PrEP prescriptions, at-home STI testing, and direct mail delivery with a similar specialty-prevention model to JUST IN CASE. Direct international comparable for the PrEP-specific vertical.
- ユナイテッドクリニック (United Clinic): Japanese men's-health clinic chain offering ED, AGA, and sexual health treatments with online consultation services. Comparable patient persona, comparable pricing structure, and comparable focus on discreet access to sensitive prescriptions.
- プライベートクリニック (Private Clinic): Japanese men's-health clinic specializing in ED, AGA, and PrEP prescriptions with online consultation options. Direct competitor for Japanese patients seeking discreet access to sexual-health prescriptions, with overlapping telemedicine-and-mail-fulfillment pattern.
- イースト駅前クリニック (East Ekimae Clinic): Large Japanese men's-health clinic chain focused on ED, AGA, and sexual health prescriptions. Comparable in addressing the same stigma-laden, cash-pay, treatment-oriented segment of Japanese patients, though predominantly in-person rather than online-first.
Emerging players
- フィットクリニック (Fit Clinic): Japanese online clinic offering ED, AGA, weight loss, and other sensitive prescriptions with online consultation and mail delivery. Emerging Japanese comparable with similar product breadth (AGA, ED, weight) that may eventually expand into STI prevention.
- MEDLEY (Mediplat / Doctors' Job): Japanese digital health company providing online medical content, doctor-matching, and clinician support tools with adjacent exposure to chronic-condition patient engagement. Emerging player with potential to extend into direct DTC prescription telemedicine.
Broad incumbents
- M3 (Medipal Holdings / m3.com): Large Japanese digital-health and physician platform operating MR-kun, QOL-kun, and other clinician-targeted services, with growing consumer-facing telemedicine. Broad incumbent with the resources to enter or absorb STI-prevention offerings, making it the most plausible large-scale competitive threat.
- Hims & Hers Health: US-listed DTC telehealth platform offering subscription-based prescription treatments for sensitive conditions (ED, hair loss, PrEP, mental health, weight loss) with discrete home delivery. Highly comparable business model: cash-pay subscription, online consultation, mail fulfillment, DTC sensitive-health positioning at much larger scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
KARADA内科クリニック financial estimates
Financial estimateRevenue estimate
Valuation estimate
KARADA内科クリニック leadership team
Management profileNumber of profiles
Profiles1 record
KARADA内科クリニック funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
KARADA内科クリニック M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about KARADA内科クリニック
What does KARADA内科クリニック do?
KARADA内科クリニック runs the JUST IN CASE online telemedicine service that provides remote physician consultations and prescriptions for STI prevention medications, including HIV PrEP (Tafero EM), HIV PEP (Taffic), and DOXY PEP (Doxycycline). Consultations are conducted entirely via LINE without requiring app installation, and prescribed medications are shipped nationwide via Yamato Transport with next-day delivery, discreet plain packaging, and optional locker pickup. The service also sells optional at-home STI test kits for HIV, hepatitis B, syphilis, gonorrhea, and chlamydia.
Is KARADA内科クリニック a public or private company?
KARADA内科クリニック is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was KARADA内科クリニック founded?
KARADA内科クリニック was founded in -1.
Where is KARADA内科クリニック based?
KARADA内科クリニック is headquartered in Tokyo, Japan, in the Asia region.
How does KARADA内科クリニック make money?
Four revenue lines are on record. HIV PEP prescription and medication sales are the primary driver. The others are HIV PrEP prescription and medication sales, DOXY PEP prescription and medication sales and optional postal STI testing.
Who are KARADA内科クリニック's main competitors?
Direct peers on record are Nurx, あおぞらクリニック (Aozora Clinic), MISTR, ユナイテッドクリニック (United Clinic), プライベートクリニック (Private Clinic) and イースト駅前クリニック (East Ekimae Clinic). Emerging players are フィットクリニック (Fit Clinic) and MEDLEY (Mediplat / Doctors' Job). Broad incumbents are M3 (Medipal Holdings / m3.com) and Hims & Hers Health.
Does KARADA内科クリニック have an API?
No public API is recorded for KARADA内科クリニック.
What industry is KARADA内科クリニック in?
KARADA内科クリニック's product category is Online Telemedicine Healthcare Services. Its primary akta.pro industry code is HLALAIAL, Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment, with a secondary code of HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription). Its NAICS code is 621111 and its SIC code is 8011.